BridgeBio Pharma
(NASDAQ:BBIO)
$25.01
-0.45[-1.77%]
At close: Apr 24
$25.01
0[0.00%]
After Hours: 4:37PM EDT
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
2
1
Jan
1
Feb
5
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About BridgeBio Pharma Inc
Sector
Health Care
Industry
Biotechnology
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients w...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BBIO
IMVT

FAQ

Q

How do I buy BridgeBio Pharma (BBIO) stock?

A

You can purchase shares of BridgeBio Pharma (NASDAQ: BBIO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BridgeBio Pharma's (BBIO) competitors?

Q

What is the target price for BridgeBio Pharma (BBIO) stock?

A

The latest price target for BridgeBio Pharma (NASDAQ: BBIO) was reported by JP Morgan on Wednesday, March 20, 2024. The analyst firm set a price target for 45.00 expecting BBIO to rise to within 12 months (a possible 79.93% upside). 18 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BridgeBio Pharma (BBIO)?

A

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $25.01 last updated Today at April 24, 2024 at 4:37 PM EDT.

Q

Does BridgeBio Pharma (BBIO) pay a dividend?

A

There are no upcoming dividends for BridgeBio Pharma.

Q

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

A

BridgeBio Pharma’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is BridgeBio Pharma (BBIO) going to split?

A

There is no upcoming split for BridgeBio Pharma.

Q

What sector and industry does BridgeBio Pharma (BBIO) operate in?

A

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch